Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.55 |
| ▸ | CCR5 | P51681 | 3/20 | 0.55 |
| ▸ | CCR8 | P51685 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.53 |
| ▸ | LMNA | P02545 | 5/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.53 |
| ▸ | TP53 | P04637 | 5/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | METAP1 | P53582 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30732403 | 1.00 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL25085704 | 0.94 | CCR1 (0.49) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL22043245 | 0.92 | CCR1 (0.47) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL2007559 | 0.91 | CCR1 (0.64) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL13311187 | 0.91 | CCR1 (0.64) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL29660049 | 0.91 | CCR1 (0.64) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL18489879 | 0.89 | CCR1 (0.62) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL2542485 | 0.87 | CCR1 (0.60) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL923281 | 0.87 | KDM4E (0.56) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL4951059 | 0.87 | KDM4E (0.70) | CCR1CCR5CCR8KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230278939-A1 | Photochemical Separations and Compositions | The Florida State University Research Foundation, Inc. | 2023-09-07 | — | — | US | disclosed |
| US-20230278939-A1 | Photochemical Separations and Compositions | The Florida State University Research Foundation, Inc. | 2023-09-07 | — | — | US | disclosed |
| US-11591277-B2 | Photochemical separations and compositions | The Florida State University Research Foundation, Inc. (US) | 2023-02-28 | — | — | US | disclosed |
| EP-2924020-B1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2019-01-16 | — | — | EP | disclosed |
| US-8343450-B2 | Functionalized carbon nanotubes, recovery of radionuclides and separation of actinides and lanthanides | CHEMNANO MATERIALS, LTD. (US) | 2013-01-01 | — | — | US | disclosed |
| US-8329011-B2 | Polymerase-immobilized electrode | CANON KABUSHIKI KAISHA (JP) | 2012-12-11 | — | — | US | disclosed |
| US-8329011-B2 | Polymerase-immobilized electrode | CANON KABUSHIKI KAISHA (JP) | 2012-12-11 | — | — | US | disclosed |
| US-8241709-B2 | Method for producing electrode having immobilized π-conjugated ligands, electrode having immobilized π-conjugated metal complexes, and electrode having immobilized π-conjugated multinuclear metal complexes | CANON KABUSHIKI KAISHA (JP) | 2012-08-14 | — | — | US | disclosed |
| US-8241709-B2 | Method for producing electrode having immobilized π-conjugated ligands, electrode having immobilized π-conjugated metal complexes, and electrode having immobilized π-conjugated multinuclear metal complexes | CANON KABUSHIKI KAISHA (JP) | 2012-08-14 | — | — | US | disclosed |
| US-8241709-B2 | Method for producing electrode having immobilized π-conjugated ligands, electrode having immobilized π-conjugated metal complexes, and electrode having immobilized π-conjugated multinuclear metal complexes | CANON KABUSHIKI KAISHA (JP) | 2012-08-14 | — | — | US | disclosed |
| US-20110006272-A1 | Electrochromic films prepared by supramolecular self-assembly | BASF SE (DE) | 2011-01-13 | — | — | US | disclosed |
| US-20110006272-A1 | Electrochromic films prepared by supramolecular self-assembly | BASF SE (DE) | 2011-01-13 | — | — | US | disclosed |
| WO-2010069797-A1 | ELECTROCHROMIC FILMS PREPARED BY SUPRAMOLECULAR SELF-ASSEMBLY | BASF SE (DE) | 2010-06-24 | — | — | WO | disclosed |
| US-20090159449-A1 | METHOD FOR PRODUCING ELECTRODE HAVING IMMOBILIZED pi-CONJUGATED LIGANDS, ELECTRODE HAVING IMMOBILIZED pi-CONJUGATED METAL COMPLEXES, AND ELECTRODE HAVING IMMOBILIZED pi-CONJUGATED MULTINUCLEAR METAL COMPLEXES | CANON KABUSHIKI KAISHA (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20090159449-A1 | METHOD FOR PRODUCING ELECTRODE HAVING IMMOBILIZED pi-CONJUGATED LIGANDS, ELECTRODE HAVING IMMOBILIZED pi-CONJUGATED METAL COMPLEXES, AND ELECTRODE HAVING IMMOBILIZED pi-CONJUGATED MULTINUCLEAR METAL COMPLEXES | CANON KABUSHIKI KAISHA (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20090159449-A1 | METHOD FOR PRODUCING ELECTRODE HAVING IMMOBILIZED pi-CONJUGATED LIGANDS, ELECTRODE HAVING IMMOBILIZED pi-CONJUGATED METAL COMPLEXES, AND ELECTRODE HAVING IMMOBILIZED pi-CONJUGATED MULTINUCLEAR METAL COMPLEXES | CANON KABUSHIKI KAISHA (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20090134042-A1 | POLYMERASE-IMMOBILIZED ELECTRODE | CANON KABUSHIKI KAISHA (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20090134042-A1 | POLYMERASE-IMMOBILIZED ELECTRODE | CANON KABUSHIKI KAISHA (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20090093664-A1 | Carbon nanotubes using for recovery of radionuclides and separation of actinides and lanthanides | CHEMNANO MATERIALS, LTD. (US) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230278939-A1 | Photochemical Separations and Compositions | APEX1, CYBA, MT-CO2 | CCR1 3867/4885CCR5 4301/4885CCR8 4134/4885 |
| US-11591277-B2 | Photochemical separations and compositions | APEX1, CYBA, MT-CO2 | CCR1 3867/4885CCR5 4301/4885CCR8 4134/4885 |
| US-20090093664-A1 | Carbon nanotubes using for recovery of radionuclides and separation of actinides and lanthanides | CLSPN, NCL, NCDN | CCR1 544/4885CCR5 2009/4885CCR8 516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.